CBP-CON-00176
Active
Federal
CSL BEHRING (AUSTRALIA) PTY LTD
Awarded by National Blood Authority
The National Blood Authority awarded CSL BEHRING (AUSTRALIA) PTY LTD a contract worth AU$271,312,775 for imported plasma and recombinant products from September 2022 to June 2027 using limited tender procurement. The contract has one amendment and falls under exemption ER — 10.3.d.ii. due to the supplier being the only reasonable alternative to protect exclusive rights or proprietary information.
$271.3M
Contract Value
Contract Details
- Reference
- CN3924655
- Jurisdiction
- Federal
- Financial Year
- FY27
- Category
- Drugs and Pharmaceutical(UNSPSC: 51000000)
Description
Imported Plasma and Recombinant Products
Key Dates
- Publish Date
- 3 July 2026
- Effective Date
- 30 Sept 2022
- End Date
- 29 June 2027
Published fields
- Procurement method
- Limited tender
- Location
- Not published in this source
Supplier
CSL BEHRING (AUSTRALIA) PTY LTD
- ABN
- 48 160 734 761
Agency
National Blood Authority
- ABN
- 87 361 602 478
Contract History
This contract has been amended 1 time.
Original Contract
Published 2 Nov 2022
$246.6M
Amendment A1
Current
Published 3 July 2026
$271.3M